Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes

European Journal of Cell Biology

Volumn 86, Issue 11-12, 2007, Pages 747-761

  Büth, Heiko ^a   Luigi Buttigieg, Pier ^a   Ostafe, Raluca ^a   Rehders, Maren ^a   Dannenmann, Stefanie R ^a   Schaschke, Norbert ^b   Stark, Hans Jürgen ^c   Boukamp, Petra ^c   Brix, Klaudia ^a  

^a JACOBS UNIVERSITY BREMEN   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cathepsin B; ECM remodeling; HaCaT; Keratinocytes; Scratch apparatus; Scratch wounding

Indexed keywords

CATHEPSIN B; COLLAGEN TYPE 4;

ANTIBODY LABELING; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; EPIDERMIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KERATINOCYTE; MICROSCOPY; MORPHOMETRICS; PRIORITY JOURNAL; WOUND HEALING;

MAMMALIA;

EID: 36048948345     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcb.2007.03.009     Document Type: Article

References (49)

1. Airola K., and Fusenig N.E. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J. Invest. Dermatol. 116 (2001) 85-92
2. Alonso L., and Fuchs E. Stem cells of the skin epithelium. Proc. Natl. Acad. Sci. USA 100 (2003) 11830-11835
3. Bajou K., Masson V., Gerard R.D., Schmitt P.M., Albert V., Praus M., Lund L.R., Frandsen T.L., Brunner N., Dano K., Fusenig N.E., Weidle U., Carmeliet G., Loskutoff D., Collen D., Carmeliet P., Foidart J.M., and Noel A. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies. J. Cell Biol. 152 (2001) 777-784
4. Balaji K.N., Schaschke N., Machleidt W., Catalfamo M., and Henkart P.A. Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. J. Exp. Med. 196 (2002) 493-503
5. Bernard D., Mehul B., Thomas-Collignon A., Simonetti L., Remy V., Bernard M.A., and Schmidt R. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsin L2. J. Invest. Dermatol. 120 (2003) 592-600
6. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
7. Brix K., and Jordans S. Watching proteases in action. Nat. Chem. Biol. 1 (2005) 186-187
8. Burk R.R. A factor from a transformed cell line that affects cell migration. Proc. Natl. Acad. Sci. USA 70 (1973) 369-372
9. Büth H., Wolters B., Hartwig B., Meier-Bornheim R., Veith H., Hansen M., Sommerhoff C.P., Schaschke N., Machleidt W., Fusenig N.E., Boukamp P., and Brix K. HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. Eur. J. Cell Biol. 83 (2004) 781-795
10. Buttle D.J., Murata M., Knight C.G., and Barrett A.J. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 299 (1992) 377-380
11. Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Guertin D.A., Chang J.H., Lindquist R.A., Moffat J., Golland P., and Sabatini D.M. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7 (2006) R100
12. Chapman H.A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9 (1997) 714-724
13. Chapman H.A., Riese R.J., and Shi G.P. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59 (1997) 63-88
14. Eeckhout Y., and Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J. 166 (1977) 21-31
15. Everts V., van der Zee E., Creemers L., and Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem. J. 28 (1996) 229-245
16. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16 (2004) 14-23
17. Fuchs E., and Raghavan S. Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 3 (2002) 199-209
18. Guinec N., Dalet-Fumeron V., and Pagano M. In vitro study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin. Biol. Chem. Hoppe Seyler 374 (1993) 1135-1146
19. Guo M., Mathieu P.A., Linebaugh B., Sloane B.F., and Reiners J.J. Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-beta a process initiated by the exocytosis of cathepsin B. J. Biol. Chem. 277 (2002) 14829-14837
20. Hackam D.J., and Ford H.R. Cellular, biochemical, and clinical aspects of wound healing. Surg. Infect. (Larchmt.) 3 (2002) S23-S35
21. Kirfel G., and Herzog V. Migration of epidermal keratinocytes: mechanisms, regulation, and biological significance. Protoplasma 223 (2004) 67-78
22. Kobayashi H., Schmitt M., Goretzki L., Chucholowski N., Calvete J., Kramer M., Gunzler W.A., Janicke F., and Graeff H. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J. Biol. Chem. 266 (1991) 5147-5152
23. Kolkhorst V., Sturzebecher J., and Wiederanders B. Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile. J. Cancer Res. Clin. Oncol. 124 (1998) 598-606
24. Kostoulas G., Lang A., Nagase H., and Baici A. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett. 455 (1999) 286-290
25. Lah T.T., Buck M.R., Honn K.V., Crissman J.D., Rao N.C., Liotta L.A., and Sloane B.F. Degradation of laminin by human tumor cathepsin B. Clin. Exp. Metastasis 7 (1989) 461-468
26. Lipton A., Klinger I., Paul D., and Holley R.W. Migration of mouse 3T3 fibroblasts in response to a serum factor. Proc. Natl. Acad. Sci. USA 68 (1971) 2799-2801
27. Maas-Szabowski N., Stärker A., and Fusenig N.E. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-α. J. Cell Sci. 116 (2003) 2937-2948
28. Mai J., Waisman D.M., and Sloane B.F. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim. Biophys. Acta 1477 (2000) 215-230
29. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
30. Mohamed M.M., and Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6 (2006) 764-775
31. Mort J.S., Magny M.C., and Lee E.R. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope. Biochem. J. 335 (1998) 491-494
32. Murphy G., and Gavrilovic J. Proteolysis and cell migration: creating a path?. Curr. Opin. Cell Biol. 11 (1999) 614-621
33. Nova D., Griel C.L., Holvoet S., Gentilhomme E., Vincent C., Staquet M.J., Schmitt D., and Serres M. Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT and HaCaT-ras-transfected cell lines. Clin. Exp. Metastasis 20 (2003) 675-683
34. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3 (2003) 489-501
35. Rawlings N.D., O'Brien E., and Barrett A.J. MEROPS: The protease database. Nucleic Acids Res. 30 (2002) 343-346
36. Reinheckel T., Deussing J., Roth W., and Peters C. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol. Chem. 382 (2001) 735-741
37. Rongone E. Skin structure, function, and biochemistry. In: Marzulli F.N., and Maibach H.I. (Eds). Dermatotoxicology (1987), Hemisphere Publishing Corporation, Washington 1-70
38. Roshy S., Sloane B.F., and Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22 (2003) 271-286
39. Roth W., Deussing J., Botchkarev V.A., Pauly-Evers M., Saftig P., Hafner A., Schmidt P., Schmahl W., Scherer J., Anton-Lamprecht I., von Figura K., Paus R., and Peters C. Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J. 14 (2000) 2075-2086
40. Schaschke N., Assfalg-Machleidt I., Machleidt W., and Moroder L. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors. FEBS Lett. 421 (1998) 80-82
41. Schaschke N., Assfalg-Machleidt I., Lassleben T., Sommerhoff C.P., Moroder L., and Machleidt W. Epoxysuccinyl peptide-derived affinity labels for cathepsin B. FEBS Lett. 482 (2000) 91-96
42. Singer A.J., and Clark R.A. Cutaneous wound healing. New Engl. J. Med. 341 (1999) 738-746
43. Štern I., Schaschke N., Moroder L., and Turk D. Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. Biochem. J. 381 (2004) 511-517
44. Watkinson A. Stratum corneum thiol protease (SCTP): a novel cysteine protease of late epidermal differentiation. Arch. Dermatol. Res. 291 (1999) 260-268
45. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83 (2003) 835-870
46. Wolf K., and Friedl P. Functional imaging of pericellular proteolysis in cancer cell invasion. Biochimie 87 (2005) 315-320
47. Wu Y.L., and Rheinwald J.G. A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas. Cell 25 (1981) 627-635
48. Yamamoto A., Kaji T., Tomoo K., Ishida T., Inoue M., Murata M., and Kitamura K. Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor. J. Mol. Biol. 227 (1992) 942-944
49. Yamamoto A., Hara T., Tomoo K., Ishida T., Fujii T., Hata Y., Murata M., and Kitamura K. Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex. J. Biochem. (Tokyo) 121 (1997) 974-977